Hanmi Pharmaceutical is a major South Korean pharmaceutical company providing comprehensive CDMO services across the entire pharmaceutical lifecycle. The company operates through Paltan Smart Plant (producing 6+ billion chemical drug tablets annually), Pyeongtaek Bioplant (FDA-approved biopharmaceutical manufacturing with 12,500L bioreactors), and Hanmi Fine Chemical (API and raw materials including mRNA cap analogs, NTP, and lipids). Hanmi has partnerships with global pharma companies including Lilly, Roche, and Sanofi.
biopharmaceutical CDMO, microbial fermentation, PEGylation and conjugation, mRNA materials, oral solid dose manufacturing, prefilled syringe manufacturing
1 site worldwide
Involvement in 13 clinical trials
No reviews available yet.
No documents available.